The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Novo Nordisk believes that by marketing such untested medicines, Hims & Hers is exposing patients to drugs that may contain dangerous impurities or incorrect amounts of active ingredients, resulting in life-jeopardizing immune reactions.
As organizations evaluate their benefits operations, many are recognizing that COBRA administration works best when it is closely connected to the broader benefits administration process.
Stepping away from an app-based program and leaning into a more personalized model can allow employers to recalibrate their wellness strategies and finally achieve measurable outcomes for their workforce.